Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133685757> ?p ?o ?g. }
- W3133685757 endingPage "107516" @default.
- W3133685757 startingPage "107516" @default.
- W3133685757 abstract "After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was deployed all around the world. To date, despite relentless efforts to control the disease by drug repurposing, there is no approved specific therapy for COVID-19. Given the role of innate and acquired immune components in the control and elimination of viral infections and inflammatory mutilations during SARS-CoV2 pathogenesis, immunotherapeutic strategies appear to be beneficent. Passive immunotherapies such as convalescent plasma, which has received much attention especially in severe cases, as well as suppressing inflammatory cytokines, interferon administration, inhibition of kinases and complement cascade, virus neutralization with key engineered products, cell-based therapies, immunomodulators and anti-inflammatory drugs are among the key immunotherapeutic approaches to deal with COVID-19, which is discussed in this review. Also, details of leading COVID-19 vaccine candidates as the most potent immunotherapy have been provided. However, despite salient improvements, there is still a lack of completely assured vaccines for universal application. Therefore, adopting proper immunotherapies according to the cytokine pattern and involved immune responses, alongside engineered biologics specially ACE2-Fc to curb SARS-CoV2 infection until achieving a tailored vaccine is probably the best strategy to better manage this pandemic. Therefore, gaining knowledge about the mechanism of action, potential targets, as well as the effectiveness of immune-based approaches to confront COVID-19 in the form of a well-ordered review study is highly momentous." @default.
- W3133685757 created "2021-03-15" @default.
- W3133685757 creator A5008498811 @default.
- W3133685757 creator A5017612256 @default.
- W3133685757 creator A5040717432 @default.
- W3133685757 creator A5043155949 @default.
- W3133685757 creator A5085700726 @default.
- W3133685757 creator A5090695737 @default.
- W3133685757 date "2021-06-01" @default.
- W3133685757 modified "2023-09-24" @default.
- W3133685757 title "An overview of some potential immunotherapeutic options against COVID-19" @default.
- W3133685757 cites W10914455 @default.
- W3133685757 cites W1485387165 @default.
- W3133685757 cites W1563183497 @default.
- W3133685757 cites W1581267528 @default.
- W3133685757 cites W1761637772 @default.
- W3133685757 cites W1800095175 @default.
- W3133685757 cites W1846100490 @default.
- W3133685757 cites W1862461292 @default.
- W3133685757 cites W1948372455 @default.
- W3133685757 cites W1961523492 @default.
- W3133685757 cites W1963838989 @default.
- W3133685757 cites W1964982019 @default.
- W3133685757 cites W1965820060 @default.
- W3133685757 cites W1966238900 @default.
- W3133685757 cites W1975490802 @default.
- W3133685757 cites W1977447968 @default.
- W3133685757 cites W1978623713 @default.
- W3133685757 cites W1979054778 @default.
- W3133685757 cites W1984832962 @default.
- W3133685757 cites W1994426264 @default.
- W3133685757 cites W1995791267 @default.
- W3133685757 cites W2000115558 @default.
- W3133685757 cites W2007446460 @default.
- W3133685757 cites W2008286188 @default.
- W3133685757 cites W2011507555 @default.
- W3133685757 cites W2012505332 @default.
- W3133685757 cites W2014988600 @default.
- W3133685757 cites W2015222073 @default.
- W3133685757 cites W2016685455 @default.
- W3133685757 cites W2020070069 @default.
- W3133685757 cites W2028305499 @default.
- W3133685757 cites W2030653181 @default.
- W3133685757 cites W2033190476 @default.
- W3133685757 cites W2033799256 @default.
- W3133685757 cites W2036272667 @default.
- W3133685757 cites W2038918691 @default.
- W3133685757 cites W2040825618 @default.
- W3133685757 cites W2043767415 @default.
- W3133685757 cites W2044255565 @default.
- W3133685757 cites W2044459637 @default.
- W3133685757 cites W2046821867 @default.
- W3133685757 cites W2051174680 @default.
- W3133685757 cites W2056022472 @default.
- W3133685757 cites W2056052081 @default.
- W3133685757 cites W2058025367 @default.
- W3133685757 cites W2060140838 @default.
- W3133685757 cites W2064168950 @default.
- W3133685757 cites W2064570818 @default.
- W3133685757 cites W2066073474 @default.
- W3133685757 cites W2070346776 @default.
- W3133685757 cites W2071049906 @default.
- W3133685757 cites W2076044667 @default.
- W3133685757 cites W2081633887 @default.
- W3133685757 cites W2081991152 @default.
- W3133685757 cites W2091671824 @default.
- W3133685757 cites W2092879755 @default.
- W3133685757 cites W2093402003 @default.
- W3133685757 cites W2094655231 @default.
- W3133685757 cites W2096092997 @default.
- W3133685757 cites W2098776090 @default.
- W3133685757 cites W2099014396 @default.
- W3133685757 cites W2099219082 @default.
- W3133685757 cites W2100708757 @default.
- W3133685757 cites W2100796791 @default.
- W3133685757 cites W2100861375 @default.
- W3133685757 cites W2103854602 @default.
- W3133685757 cites W2106634947 @default.
- W3133685757 cites W2107509709 @default.
- W3133685757 cites W2110223801 @default.
- W3133685757 cites W2117458024 @default.
- W3133685757 cites W2121986684 @default.
- W3133685757 cites W2124079316 @default.
- W3133685757 cites W2130158896 @default.
- W3133685757 cites W2132460437 @default.
- W3133685757 cites W2133010278 @default.
- W3133685757 cites W2135926866 @default.
- W3133685757 cites W2135953873 @default.
- W3133685757 cites W2138201661 @default.
- W3133685757 cites W2146354741 @default.
- W3133685757 cites W2146476111 @default.
- W3133685757 cites W2155601189 @default.
- W3133685757 cites W2158924104 @default.
- W3133685757 cites W2162732275 @default.
- W3133685757 cites W2167701694 @default.
- W3133685757 cites W2169792884 @default.
- W3133685757 cites W2169880106 @default.
- W3133685757 cites W2171907379 @default.